Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: A post-hoc analysis of a double-blind, randomized, placebo-controlled study

Critical Care

Volumn 15, Issue 5, 2011, Pages

  Devlin, John W ^a,b   Skrobik, Yoanna ^c   Riker, Richard R ^d   Hinderleider, Eric ^a   Roberts, Russel J ^b   Fong, Jeffrey J ^e   Ruthazer, Robin ^b   Hill, Nicholas S ^b   Garpestad, Erik ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^d MAINE MEDICAL CENTER   (United States)

^e MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; PLACEBO; QUETIAPINE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

AGITATION; APACHE; ARTICLE; ATTENTION DISTURBANCE; CHECKLIST; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DELIRIUM; DELUSION; DISEASE DURATION; DISORIENTATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; EXPLORATORY RESEARCH; HALLUCINATION; HUMAN; HYPERACTIVITY; INTENSIVE CARE; MOOD DISORDER; POST HOC ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP DISORDER; SPEECH DISORDER; TIME; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; CRITICAL ILLNESS; DELIRIUM; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; HALOPERIDOL; HUMANS; PLACEBOS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80052824087     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10450     Document Type: Article

References (33)

1. Skrobik Y. Delirium prevention and treatment. Crit Care Clin 2009, 25:585-91. 10.1016/j.ccc.2009.05.003, 19576532.
2. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 2007, 33:66-73. 10.1007/s00134-006-0399-8, 17102966.
3. Ely EW, Gautam S, Margolin R, Francis J, May L, Speroff T, Truman B, Dittus R, Bernard R, Inouye SK. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001, 27:1892-1900. 10.1007/s00134-001-1132-2, 11797025.
4. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004, 291:1753-1762. 10.1001/jama.291.14.1753, 15082703.
5. Shehabi Y, Riker RR, Bokesch PM, Wisemandle W, Shintani A, Ely EW. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care unit patients. Crit Care Med 2010, 38:2311-2318. 10.1097/CCM.0b013e3181f85759, 20838332.
6. Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009, 180:1092-1097. 10.1164/rccm.200904-0537OC, 2784414, 19745202.
7. Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, Gordon SM, Canonico AE, Dittus RS, Bernard GR, Ely EW. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010, 38:1513-1520. 10.1097/CCM.0b013e3181e47be1, 20473145.
8. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001, 27:859-864. 10.1007/s001340100909, 11430542.
9. Neufeld KJ, Hayat MJ, Coughlin JM, Huberman AL, Leistikow NA, Krumm SK, Needham DM. Evaluation of two intensive care delirium screening tools for non-critically ill hospitalized patients. Psychosomatics 2011, 52:133-140.
10. Luetz A, Heymann A, Radtke FM, Chenitir C, Neuhaus U, Nachtigall I, von Dossow V, Marz S, Eggers V, Heinz A, Wernecke KD, Spies CD. Different assessment tools for intensive care unit delirium: Which score to use?. Crit Care Med 2010, 38:409-418. 10.1097/CCM.0b013e3181cabb42, 20029345.
11. Devlin JW, Fong JJ, Schumaker G, O'Connor H, Ruthazer R, Garpestad E. Use of a validated delirium assessment tool improves the ability of physicians to identify delirium in medical intensive care unit patients. Crit Care Med 2007, 35:2721-2724. 10.1097/01.CCM.0000292011.93074.82, 18074477.
12. Devlin JW, Marquis F, Riker RR, Robbins T, Garpestad E, Fong JJ, O'Connor H, Ruthazer R, Garpestad E, Fong JJ, Didomenico D, Skrobik Y. Combined didactic and scenario-based education improves the ability of intensive care unit staff to recognize delirium at the bedside. Crit Care 2008, 12:R19. 10.1186/cc6793, 2374631, 18291021.
13. Skrobik Y, Devlin JW. The intensive care delirium screening checklist has many potential benefits over the nursing delirium screening scale. Crit Care Med 2010, 38:1610-1611. author reply 1611-1612.
14. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, Speroff T, Gautam S, Bernard GR, Inouye SK. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001, 29:1370-1379. 10.1097/00003246-200107000-00012, 11445689.
15. Ouimet S, Riker R, Bergeron N, Cossette M, Kavanagh B, Skrobik Y. Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med 2007, 33:1007-1013. 10.1007/s00134-007-0618-y, 17404704.
16. Cole M, McCusker J, Dendukuri N, Han L. The prognostic significance of subsyndromal delirium in elderly medical inpatients. J Am Geriatr Soc 2003, 51:754-760. 10.1046/j.1365-2389.2003.51255.x, 12757560.
17. Meagher D, Trzepacz PT. Phenomenological distinctions needed in DSM-V: Delirium, subsyndromal delirium and dementias. J Neuropsychiatry Clin Neurosci 2007, 19:468-470. 10.1176/appi.neuropsych.19.4.468, 18070853.
18. Gupta N, de Jonghe J, Schieveld J, Leonard M, Meagher D. Delirium phenomenology: what can we learn from the symptoms of delirium?. J Psychosom Res 2008, 65:215-222. 10.1016/j.jpsychores.2008.05.020, 18707943.
19. Devlin JW, Skrobik Y. Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role?. Harv Rev Psychiatry 2011, 19:59-67. 10.3109/10673229.2011.565247, 21425934.
20. Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, Robbins T, Garpestad E. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010, 38:419-427. 10.1097/CCM.0b013e3181b9e302, 19915454.
21. Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, Pun BT, Thompson JL, Shintani AK, Meltzer HY, Bernard GR, Dittus RS, Ely EW, . MIND Trial Investigators Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 2010, 38:428-437. 10.1097/CCM.0b013e3181c58715, 20095068, MIND Trial Investigators.
22. Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004, 30:444-449. 10.1007/s00134-003-2117-0, 14685663.
23. Heymann A, Radtke F, Schiemann A, Lütz A, MacGuill M, Wernecke KD, Spies C. Delayed treatment of delirium increases mortality rate in intensive care unit patients. J Int Med Res 2010, 38:1584-1595.
24. Seitz DP, Gill SS, van Zyl LT. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry 2007, 68:11-21. 10.4088/JCP.v68n0102, 17900204.
25. Seeman P. Atypical antipsychotics: mechanisms of action. Can J Psychiatry 2002, 47:27-28.
26. Marquis F, Ouimet S, Riker R, Cossette M, Skrobik Y. Individual delirium symptoms: do they matter?. Crit Care Med 2007, 35:2533-2537. 10.1097/01.CCM.0000284506.43390.F3, 18084841.
27. Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Pychosomatics 2009, 50:206-217.
28. van Eijk MJM, Roes KCB, Honing MLH, Kuiper MA, Karakus A, van der Jagt M. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010, 376:1829-1837. 10.1016/S0140-6736(10)61855-7, 21056464.
29. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 373:1874-1882. 10.1016/S0140-6736(09)60658-9, 19446324.
30. Reade MC, O'Sullivan K, Bates S, Goldsmith D, Ainslie WR, Bellomo R. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care 2009, 13:R75. 10.1186/cc7890, 2717438, 19454032.
31. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG, . SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009, 301:489-499. 10.1001/jama.2009.56, 19188334, SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group.
32. Skrobik Y, Ahern S, Leblanc M, Marquis F, Awissi DK, Kavanagh BP. Protocolized ICU management of analgesia, sedation and delirium improves the analgesia and subsyndromal delirium rates. Anesth Analg 2010, 111:451-463. 10.1213/ANE.0b013e3181d7e1b8, 20375300.
33. Tahir TA, Eeles E, Karapareddy V, Muthevelu P, Chapple S, Phillips B, Adyemo T, Farewell D, Bisson JI. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosomatic Res 2010, 69:485-490.